{"version":"1.0","type":"link","title":"The impact of the number of prior androgen receptor pathway inhibitors before cabazitaxel treatment in patients with metastatic castration-resistant prostate cancer.","author_name":"Taniguchi H 외","author_url":"https://prs-insight.online/author/Taniguchi%20H","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/138276","thumbnail_width":1200,"thumbnail_height":630}